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Abstract
Inositol 1,4,5-trisphosphate receptor (IP3-receptor) is a calcium channel, transporting calcium from intracellular stores to
the cytoplasm. In kidney, IP3-receptors are involved in the signal transduction of various hormones. In our work we studied
the effect of immobilization stress on the IP3-receptor’s protein content in renal cortex and the medulla of normotensive and
hypertensive rats. We detected both mRNA and type 1 IP3-receptor protein in medulla, but not in renal cortex. We found
that this receptor was approximately twice as abundant in normotensive as in genetically hypertensive rat kidney.
Immobilization stress decreased the amount of type 1 IP3-receptor in the renal medulla of normotensive rats approximately
five times, while no effect due to single and/or repeated stress was observed in the renal medulla of spontaneously
hypertensive rats. The results indicate that expression of type 1 IP3-receptor in renal medulla is modulated by hypertension
and immobilization stress. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
An increase in the cytosolic free calcium occurs as
an integral component in the alteration of cellular
responses produced by a variety of hormones. Part
of this increase originates from an intracellular com-
partment. Inositol 1,4,5-trisphosphate (IP3) is a sec-
ond messenger, which mobilizes calcium from intra-
cellular stores [1^3]. IP3 binds to its receptors (IP3-
receptors), which induces the release of calcium from
the endoplasmic reticulum [4]. To date, three genes
for mammalian IP3-receptor were found, giving three
IP3-receptor subtypes, type 1, 2 and 3 [5,6]. These
types of IP3-receptor are approximately 70% identi-
cal at the amino acid level and were observed in
many di¡erent tissues and cells, with various sub-
types and distribution [7,8]. In kidney, all three types
of IP3-receptor were found [9]. Type 1 was detected
in glomerular mesangial cells and vascular smooth
muscle cells. Type 2 was expressed exclusively in in-
tercalated cells of collecting ducts from the cortex to
the inner medulla. Type 3 was expressed in vascular
smooth muscle cells, glomerular mesangial cells and
some cells of cortical collecting ducts, probably prin-
cipal cells [10]. Yang et al. [11] proposed that di¡er-
ent types of IP3 receptors might have di¡erent func-
tions in the rat kidney.
IP3-receptors serve as intracellular calcium release
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channels involved in signal transduction of various
hormones in the kidney. Alterations in IP3-receptor
amount or in its distribution in the kidney may con-
tribute to its dysfunction. For example, it was al-
ready shown that there is down-regulated type
1 IP3-receptor in glomerular and vascular cells in
diabetic kidney, which may contribute to the renal
vasoregulation and renal hypertrophy during diabe-
tes [12].
Stress is a stimulus, which could alter the protein
expression and/or the function of the IP3-receptor.
Stress is known to be deeply involved in the develop-
ment of serious health complications, such as hyper-
tension or heart failure. Immobilization is proved to
be one of the most potent stress models [13], since it
activates both components of the sympathoadrenal
system, i.e. adreno-medullar and sympathoneural.
Moreover, immobilization was found to a¡ect en-
zymes, receptors and membrane proteins not only
on the activity level (catecholamines [14], plasma re-
nin activity [15]), but also in the protein amount (ty-
rosine hydroxylase [16], Na/Ca2 exchanger, Ca2-
channel [17]) and/or the gene expression (K1 subunit
of Ca2-channels, catecholamine biosynthetic en-
zymes, renin, etc. [18]).
The aim of the current study was to investigate a
possible correlation between the amount of mRNA
and type 1 IP3-receptor in kidney under control and
pathophysiological conditions. We focused on the
comparison of the IP3-receptor in renal cortex and/
or medulla in normotensive and spontaneously hy-
pertensive rat strains. Since the immobilization stress
is a strong stimulus a¡ecting the sympathoadrenal
system, we also compared the mRNA and protein
levels of IP3-receptor of type 1 in the kidney of im-
mobilized animals in comparison to unstressed ani-
mals.
2. Materials and methods
2.1. Animals
The Animal Care Committee of the Slovak Acad-
emy of Sciences, Bratislava, Slovak Republic ap-
proved the protocol used. The investigation con-
formed to the Guide for the Care and Use of
Laboratory Animals published by the US National
Institute of Health. Normotensive Wistar-Kyoto
(WKY) and spontaneously hypertensive (SHR)
three-month-old male rats were used for all experi-
ments. Before initiation of the experimental proce-
dures, the animals were housed 3^4 per cage for at
least 7 days. The room temperature was maintained
at 23 þ 2‡C and periodic 12-h alternation of light and
dark was performed during the whole experiment.
Food and water were available ad libitum. During
the experiment, animals were weighed on a labora-
tory balance. Blood pressure was measured by the
tail-cu¡ procedure.
2.2. Immobilization stress
In our experiments we used the immobilization
protocol described by Kvetn›ansky¤ and Mikulaj
[13]. Rats were immobilized one or seven times for
30 min or 2 h, except for a control group. Animals
were killed either immediately after the last immobi-
lization or 3 and 24 h later. The renal cortex and
medulla were dissected, dried from blood, washed
in ice cold physiological solution and frozen in liquid
nitrogen.
As a positive control for IP3 receptor type 1, the
rat brain cerebellum and hypothalamus of unstressed
controls were used. The hypothalamus was removed
as a complete area. One third of the right hemisphere
of the cerebellum was separated by scissors. Tissues
were rapidly frozen in liquid nitrogen.
2.3. Western blot analysis
Protein assays were done by the Lowry method
[19]. A sample of each protein extract (20 Wg of total
protein) was separated by electrophoresis on a 6.5%
sodium dodecyl sulfate^polyacrylamide gel [20] and
then transferred to a nitrocellulose membrane, using
a semi-dry blotting. The blot was blocked in 5% non-
fat dry milk diluted in TBST and then incubated
with the polyclonal antibody against IP3 type 1 re-
ceptor (a gift of Professor Walaas and Dr. L.S.
Haug, University of Oslo, Norway). This antibody
was raised against an 18 amino acid synthetic peptide
corresponding to the carboxy-terminal end of the
type 1 IP3 receptor from rat. Since the carboxy-ter-
mini of the IP3 receptor’s subtype are di¡erent, this
antibody recognizes very speci¢cally only type 1 IP3
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receptor [21,22]. We used a secondary anti-rabbit
antibody labeled by peroxidase (Calbiochem). The
protein bands (240 kDa) were detected with a sensi-
tive chemiluminescent detection system-ECL (Amer-
sham, UK). A calibration curve with di¡erent
amounts of protein extract (2, 5, 10, 15, 20 and
30 mg of total protein) was made to check the accu-
racy of protein loaded. The optical density of the
individual bands was quanti¢ed using a Kodak cam-
era and IMAGE software.
2.4. RNA preparation
RNA was isolated from the renal cortex and me-
dulla according to the procedure of Chomczynski
and Sacchi [23], using guanidine isothiocyanate
(Fisher Scienti¢c, USA) and phenol^chloroform ex-
traction. The concentration and purity of RNA was
determined in triplicate spectrophotometrically on
Shimadzu UV 3000.
2.5. Relative quanti¢cation of mRNA levels by reverse
transcription and polymerase chain reaction
(RT-PCR)
Reverse transcription was performed from 5 Wg of
total RNA using Ready-To-Go1 You-Prime First
Strand Beads (Amersham Pharmacia Biotech) and
pd(N)6 primer. Speci¢c PCR for the type 1 IP3-re-
ceptor was done afterwards using primers as de-
scribed in Genazzani et al. [24] (forward: 5P-GTG
GAG GTT TCA TCT GCA AGC-3P ; reverse: 5P-
GCT TTC GTG GAA TAC TCG GTC-3P). After
initial denaturation at 94‡C for 5 min we used
35 cycles of denaturation at 94‡C for 1 min, anneal-
ing at 60‡C for 1 min and polymerization at 72‡C for
1 min. PCR was completed by the ¢nal polymeriza-
tion at 72‡C for 7 min. These primers are known to
amplify two splice variants of type 1 IP3 receptor, a
neuronal 535 bp fragment and nonneuronal 410 bp
fragment [24].
Since it is known that the fragment ampli¢cation
by PCR is linear only at a limited number of cycles,
prior to the experiment we ampli¢ed the fragment of
type 1 IP3-receptor using 10, 15, 17, 20, 23, 25, 27,
30, 32, 35, 37, 40 and 45 cycles. The ampli¢cation
curve was linear between 27^45 cycles. Therefore,
35 cycles used were appropriate for our experiments.
2.6. Statistical analyses
Each value represents an average for six animals.
Results are presented as means þ S.E.M. Statistical
di¡erences among groups were determined by one
way analysis of variance (ANOVA). Statistical sig-
ni¢cance was de¢ned as P6 0.05. For multiple com-
parisons, an adjusted t-test with P-values corrected
by the Bonferroni method was used (Instat, Graph-
Pad Software, USA).
3. Results
The blood pressure and body weight are important
parameters for animal characterization. Therefore,
Fig. 1. mRNA levels of type 1 IP3-receptor in renal cortex and
medulla. In the upper part (A) there is a typical result of PCR
of IP3 receptor fragment from the cortex (WKY-C, SHR-C)
and medulla (WKY-M, SHR-M) of WKY and SHR rats. As a
positive control, cerebellum (cer) and hypothalamus (hyp) were
ampli¢ed. In cerebellum, a longer splice variant (535 bp) was
observed, while in hypothalamus, both variants (535 and
410 bp) were detected. In renal medulla, only the 410 bp splice
variant of type 1 IP3-receptor was noticed. The graph in part
(B) represents a statistical evaluation of PCR results in renal
cortex and medulla. Each column is displayed as mean þ S.E.M.
and each value represents an average of six animals. In WKY
renal medulla, the amount of mRNA of type 1 IP3-receptor
was almost twice as high as in SHR (P6 0.001). In renal me-
dulla, no signal for mRNA of IP3-receptor of type 1 was ob-
served.
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we checked the body weight and blood pressure of
both strains of rats, in order to con¢rm the devel-
oped hypertension in SHR. The body weight of SHR
animals was signi¢cantly lower compared to normo-
tensive WKY rats (273.0 þ 3.3 g in SHR versus
320.3 þ 6.9 g in WKY). Nonetheless, the blood pres-
sure was signi¢cantly elevated in SHR, compared to
WKY (from 105.1 þ 4.4 to 167.3 þ 2.3 mm Hg). Nei-
ther body weight, nor blood pressure was signi¢-
cantly changed by the immobilization.
We determined type 1 IP3-receptor on both
mRNA and protein levels. In the renal medulla of
both WKY and SHR rats, we have found mRNA of
a shorter splice variant of type 1 IP3-receptor (Fig.
1). No signal was obtained from the renal cortex. As
a positive control, we used mRNA from cerebellum
and hypothalamus. In these parts of the brain, a
longer splice variant was detected. Moreover, in the
hypothalamus we detected also a shorter splice var-
iant.
Kidney cortex and medulla membrane proteins
were subjected also to the Western blot analysis to
determine whether antibody against the IP3-receptor
of type 1 will recognize corresponding protein in
these fractions. Since the IP3-receptor of type 1 is
highly expressed in cerebellum, we used the cerebel-
lum microsomes as a positive control. Polyclonal
antibody against the IP3-receptor of type 1 labeled
the protein with Mw 240 kDa in the cerebellum and
in the kidney medulla, but not in the kidney cortex
(Fig. 2, left). The concentration dependence of type
1 IP3-receptor in the renal medulla of WKY rats is
shown in Fig. 2, right. Immobilization stress down-
regulated the protein of the IP3-receptor of type 1 rat
Fig. 2. IP3 receptor type 1 protein in kidney cortex (-C) and medulla (-M) of normotensive WKY and hypertensive SHR rats. Cere-
bellum (Cer) serves as a positive control. Typical result of Western blot and subsequent hybridization with polyclonal antibody against
this receptor is in the left part of the ¢gure. Concentration curve with di¡erent amounts of proteins loaded on gel is shown in the
right part of the ¢gure. Graph represents an average from six animals and results are displayed as mean þ S.E.M.
Fig. 3. The e¡ect of immobilization stress on the IP3-receptor
of type 1 in renal medulla of normotensive rats. In renal me-
dulla of normotensive rats, immobilization decreased the
amount of IP3-receptor of type 1 after 120 min of immobiliza-
tion. This amount decreased approximately ¢ve times after sin-
gle (IMO1) immobilization (#P6 0.001) compared to control
values at time 0 min. After 3 h of rest, a signi¢cant decrease in
the amount of this receptor was still observed. After 24 h of
rest, the protein amount of the IP3-receptor of type 1 returned
to the control levels.
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medulla in normotensive WKY rats after 2 h of im-
mobilization (Fig. 3). No IP3-receptor of type 1 was
observed in the renal cortex of WKY and SHR after
immobilization (not shown). When animals were im-
mobilized only for 30 min, no signi¢cant decrease of
type 1 IP3-receptor was observed. After a 24 h rest,
the amount of IP3-receptor of type 1 returned to the
original level (Fig. 3). We also compared the mRNA
and protein levels of type 1 IP3-receptor between
WKY and SHR rats in renal medulla under the con-
trol conditions and after the immobilization stress.
Both the mRNA and protein levels of IP3R1 were
signi¢cantly higher (P6 0.01) in the control group
(AC) of WKY rats compared to SHR rats (Fig. 4).
Although the e¡ect of immobilization stress on the
mRNA (Fig. 4A) and protein (Fig. 4B) level of the
IP3-receptor of type 1 in the renal medulla was ob-
served in WKY rats, immobilization had no e¡ect on
the IP3-receptor of type 1 in SHR rats. On the
mRNA level, single immobilization of WKY rats
causes approximately a two-fold down-regulation of
type 1 IP3 receptor, while after repeated immobiliza-
tion for seven times, a profound decrease was ob-
served (Fig. 4A). The single immobilization (IMO1)
for 2 h and repeated immobilization (IMO7) signi¢-
cantly decreased the protein level of the IP3R1 com-
pared to the control groups (from 5.37 þ 0.99 to
1.1 þ 0.78 arbitrary units, Fig. 4B).
4. Discussion
The present results indicate for the ¢rst time that
(i) the IP3-receptor of type 1 was down- regulated in
renal medulla of SHR compared to WKY animals
on both mRNA and protein levels and (ii) in WKY
renal medulla, a rapid down-regulation of the IP3-
receptor of type 1 occurred after the single and re-
peated immobilization for 2 h.
Immobilization stress is known to regulate several
Ca2-transport systems in di¡erent tissues [17,25,26].
However, these Ca2-transport systems were found
to be up-regulated by immobilization. The possible
mechanism of this e¡ect might involve catecholamine
or glucocorticoid regulation, since both catechol-
amines and glucocorticoids are rapidly increased by
this stress stimulus [27]. Down-regulation of type
1 IP3 receptor in renal medulla might point to a
di¡erent regulatory mechanism of this Ca2-trans-
port system and to its speci¢c role during immobili-
zation stress in renal medulla. The physiological rele-
vance of this observation remains to be proven.
Down-regulation of the IP3-receptor of type 1 in
kidney may decrease the local intracellular calcium
concentration and might a¡ect the signal transduc-
tion of renal hormones. Sharma et al. [12] demon-
strated that the IP3-receptor protein of type 1 is re-
duced in glomerular cells and vascular smooth
muscle cells of the diabetic rat in association with
Fig. 4. mRNA (A) and protein (B) levels of type 1 IP3-recep-
tors in renal medulla of WKY (empty columns) and SHR
(¢lled columns) rats during immobilization. AC, absolute con-
trols; IMO1, animals were immobilized once for 2 h and de-
capitated immediately after the end of stimulus; IMO7, animals
were immobilized seven times for 2 h with a subsequent 22 h
rest and decapitated immediately after the end of the last im-
mobilization. Gels represent a typical result and graphs repre-
sent an average of six animals. Results are displayed as
mean þ S.E.M.
BBAMEM 77831 12-5-00
Lí . Zí a¤c›ikova¤ et al. / Biochimica et Biophysica Acta 1466 (2000) 16^2220
development of renal hypertrophy and creatinine
clearance. Regulation of IP3-receptor expression is
likely to have functional consequences. Reduction
of the type 1 IP3-receptor protein expression has pre-
viously been shown to result in decreased IP3 sensi-
tivity and [Ca2]i release in response to IP3 mobiliz-
ing agonists in neuroblastoma cells and rat liver
epithelial cells [28].
In renal medulla of SHR rats, the type 1 IP3-re-
ceptor was down-regulated on both mRNA and pro-
tein levels. The physiological relevance of this obser-
vation is not clear yet. However, it was found that
the renal alpha 1-adrenergic receptor coupling to
phospholipase C is less e⁄cient in SHR than in
WKY [29]. This would result in lower IP3 production
and thus in a decreased requirement of IP3 receptors.
Nevertheless, this hypothesis remains to be tested.
The signal for the down-regulation of the IP3-re-
ceptors is probably caused by IP3 binding [30]. Since
the sensitivity of individual IP3-receptor subtypes to
IP3 is di¡erent [31], it might be suggested that the
sensitivity of these IP3-receptor subtypes to down-
regulation is di¡erent. It is tempting to speculate
that immobilization stress might thus elevate the
phosphatidylinositol 4,5-bisphosphate turnover, pos-
sibly by activation of phosphoinositidase C. In reno-
medullary interstitial cells, angiotensin II was also
shown to increase the intracellular IP3 concentration
as well as the intracellular calcium concentration
[32]. In SHR renal medulla, increased angiotensin
II levels might further elevate the intracellular IP3
concentration, which would result in the down-regu-
lation of IP3-receptors of type 1.
In summary, we have found both mRNA and pro-
tein of type 1 IP3-receptor in renal medulla, but not
in renal cortex of WKY and SHR rats. We have
shown that in renal medulla, this receptor is modu-
lated by immobilization stress in normotensive, but
not in hypertensive animals. The physiological rele-
vance of this observation remains to be elucidated.
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